Kyverna Therapeutics, Inc. (KYTX)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
7. 8200
-0.08
-1.01%
$
376.17M Market Cap
- P/E Ratio
- Div Yield
802,629 Volume
- Eps
$ 7.9
Previous Close 
Want to track KYTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KYTX Earnings Reports FAQ
What is the earnings per share (EPS) for KYTX?
EPS data for KYTX is currently not available, as Kyverna Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Kyverna Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kyverna Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kyverna Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KYTX at this time, as Kyverna Therapeutics, Inc has no recent EPS data to calculate it.
